Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:FCSC

Fibrocell Science (FCSC) Stock Price, News & Analysis

Fibrocell Science logo

About Fibrocell Science Stock (NASDAQ:FCSC)

Advanced Chart

Key Stats

Today's Range
$3.00
$3.00
50-Day Range
$3.00
$3.00
52-Week Range
$1.45
$3.28
Volume
N/A
Average Volume
78,673 shs
Market Capitalization
$29.28 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive FCSC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fibrocell Science and its competitors with MarketBeat's FREE daily newsletter.

FCSC Stock News Headlines

Best Data Science Bootcamps Online In 2024
Science & Tech News
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
Oramed Pharmaceuticals
See More Headlines

FCSC Stock Analysis - Frequently Asked Questions

Fibrocell Science Inc (NASDAQ:FCSC) posted its quarterly earnings results on Wednesday, August, 14th. The company reported $1.12 earnings per share for the quarter, beating analysts' consensus estimates of ($0.18) by $1.30. The business earned $21.79 million during the quarter.

Fibrocell Science shares reverse split on the morning of Friday, May 25th 2018.The 1-5 reverse split was announced on Thursday, May 24th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, May 24th 2018. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Fibrocell Science investors own include Carlyle Group (CG), Celldex Therapeutics (CLDX), Neos Therapeutics (NEOS), Amarin (AMRN), OPKO Health (OPK), NextTrip (NTRP) and Sorrento Therapeutics (SRNE).

Company Calendar

Last Earnings
8/14/2019
Today
7/11/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:FCSC
CIK
357097
Fax
N/A
Employees
19
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.45)
Trailing P/E Ratio
N/A
Forward P/E Ratio
30.00
P/E Growth
N/A
Net Income
-$10.28 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
23.10%
Return on Assets
10.56%

Debt

Debt-to-Equity Ratio
0.47
Current Ratio
5.09
Quick Ratio
5.09

Sales & Book Value

Annual Sales
$350 thousand
Price / Sales
83.66
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.98 per share
Price / Book
3.06

Miscellaneous

Outstanding Shares
9,760,000
Free Float
N/A
Market Cap
$29.28 million
Optionable
Optionable
Beta
1.67
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (NASDAQ:FCSC) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners